miR-375 inhibits the proliferation of gastric cancer cells by repressing ERBB2 expression

EXPERIMENTAL AND THERAPEUTIC MEDICINE - Tập 7 Số 6 - Trang 1757-1761 - 2014
Zhiyong Shen1, Z H Zhang1, Hua Liu1, Enhao Zhao1, Hui Cao1
1Department of General Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 201112, P.R. China.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Danaei, 2005, Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors, Lancet, 366, 1784, 10.1016/S0140-6736(05)67725-2

Delaunoit, 2011, Latest developments and emerging treatment options in the management of stomach cancer, Cancer Manag Res, 3, 257, 10.2147/CMAR.S12713

Bang, 2012, Advances in the management of HER2-positive advanced gastric and gastroesophageal junction cancer, J Clin Gastroenterol, 46, 637, 10.1097/MCG.0b013e3182557307

Hofmann, 2008, Assessment of a HER2 scoring system for gastric cancer: results from a validation study, Histopathology, 52, 797, 10.1111/j.1365-2559.2008.03028.x

Park, 2012, Comprehensive analysis of HER2 expression and gene amplification in gastric cancers using immunohistochemistry and in situ hybridization: which scoring system should we use?, Hum Pathol, 43, 413, 10.1016/j.humpath.2011.05.019

Fassan, 2012, Early HER2 dysregulation in gastric and oesophageal carcinogenesis, Histopathology, 61, 769, 10.1111/j.1365-2559.2012.04272.x

Wu, 2010, MicroRNA dysregulation in gastric cancer: a new player enters the game, Oncogene, 29, 5761, 10.1038/onc.2010.352

Nicoloso, 2009, MicroRNAs - the micro steering wheel of tumour metastases, Nat Rev Cancer, 9, 293, 10.1038/nrc2619

Ueda, 2010, Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis, Lancet Oncol, 11, 136, 10.1016/S1470-2045(09)70343-2

Avissar, 2009, MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma, Clin Cancer Res, 15, 2850, 10.1158/1078-0432.CCR-08-3131

Mathé, 2009, MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival, Clin Cancer Res, 15, 6192, 10.1158/1078-0432.CCR-09-1467

Liu, 2010, MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties, Biochem Biophys Res Commun, 394, 623, 10.1016/j.bbrc.2010.03.036

Ding, 2010, MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2, Cell Res, 20, 784, 10.1038/cr.2010.79

Tsukamoto, 2010, MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta, Cancer Res, 70, 2339, 10.1158/0008-5472.CAN-09-2777

Washington, 2010, 7th edition of the AJCC cancer staging manual: stomach, Ann Surg Oncol, 17, 3077, 10.1245/s10434-010-1362-z

Rüschoff, 2012, HER2 testing in gastric cancer: a practical approach, Mod Pathol, 25, 637, 10.1038/modpathol.2011.198